Brian M. Goff
Brian M. Goff is on the board of Pathways to College Network and Chief Commercial, Global Operations Officer & EVP at Alexion Pharmaceuticals, Inc.
He previously occupied the position of Chief Operating Officer & Director at Neurovance, Inc., Executive Vice President & President-Hematology at Baxalta, Inc., VP, Head-Primary Care & Established medicines at Novartis Pharmaceuticals Corp. and Head-Global Hemophilia Franchise at Baxter Healthcare Corp.
Brian M. Goff received an undergraduate degree from Skidmore College and an MBA from The Wharton School of the University of Pennsylvania.
Transactions
Date
Transaction
Value
| 12/16/2020 | 3,261 | Derivative/Non-derivative trans. at $157.96 per share. | 515,108 |
| 12/16/2020 | 18,134 | Derivative/Non-derivative trans. at $157.96 per share. | 2,864,447 |
| 12/16/2020 | 40,677 | Award at $0 per share. | 0 |
| 06/08/2020 | 1,642 | Derivative/Non-derivative trans. at $114.61 per share. | 188,190 |
| 03/02/2020 | 1,401 | Derivative/Non-derivative trans. at $90.54 per share. | 126,847 |
| 02/28/2020 | 10,880 | Award at $0 per share. | 0 |
| 02/07/2020 | 1,594 | Derivative/Non-derivative trans. at $102.97 per share. | 164,135 |
| 06/07/2019 | 1,643 | Derivative/Non-derivative trans. at $118.61 per share. | 194,877 |
| 02/28/2019 | 9,428 | Award at $0 per share. | 0 |
| 02/28/2019 | 670 | Derivative/Non-derivative trans. at $132.93 per share. | 89,064 |
| 02/07/2019 | 1,596 | Derivative/Non-derivative trans. at $119.57 per share. | 190,834 |
| 06/08/2018 | 1,645 | Disposition at $118.53 per share. | 194,982 |
| 02/28/2018 | 8,940 | Award at $0 per share. | 0 |
| 02/08/2018 | 1,651 | Disposition at $116.31 per share. | 192,028 |
| 02/06/2018 | 15,894 | Award at $0 per share. | 0 |
| 06/07/2017 | 14,719 | Award at $0 per share. | 0 |
